Anti-inflammatory activity of Chios mastic gum is associated with inhibition of TNF-alpha induced oxidative stress

Angelike Triantafyllou, Alfiya Bikineyeva, Anna Dikalova, Rafal Nazarewicz, Stamatios Lerakis, Sergey Dikalov, Angelike Triantafyllou, Alfiya Bikineyeva, Anna Dikalova, Rafal Nazarewicz, Stamatios Lerakis, Sergey Dikalov

Abstract

Background: Gum of Chios mastic (Pistacia lentiscus var. chia) is a natural antimicrobial agent that has found extensive use in pharmaceutical products and as a nutritional supplement. The molecular mechanisms of its anti-inflammatory activity, however, are not clear. In this work, the potential role of antioxidant activity of Chios mastic gum has been evaluated.

Methods: Scavenging of superoxide radical was investigated by electron spin resonance and spin trapping technique using EMPO spin trap in xanthine oxidase system. Superoxide production in endothelial and smooth muscle cells stimulated with TNF-α or angiotensin II and treated with vehicle (DMSO) or mastic gum (0.1-10 μg/ml) was measured by DHE and HPLC. Cellular H2O2 was measured by Amplex Red. Inhibition of protein kinase C (PKC) with mastic gum was determined by the decrease of purified PKC activity, by inhibition of PKC activity in cellular homogenate and by attenuation of superoxide production in cells treated with PKC activator phorbol 12-myristate 13-acetate (PMA).

Results: Spin trapping study did not show significant scavenging of superoxide by mastic gum itself. However, mastic gum inhibited cellular production of superoxide and H2O2 in dose dependent manner in TNF-α treated rat aortic smooth muscle cells but did not affect unstimulated cells. TNF-α significantly increased the cellular superoxide production by NADPH oxidase, while mastic gum completely abolished this stimulation. Mastic gum inhibited the activity of purified PKC, decreased PKC activity in cell homogenate, and attenuated superoxide production in cells stimulated with PKC activator PMA and PKC-dependent angiotensin II in endothelial cells.

Conclusion: We suggest that mastic gum inhibits PKC which attenuates production of superoxide and H2O2 by NADPH oxidases. This antioxidant property may have direct implication to the anti-inflammatory activity of the Chios mastic gum.

Figures

Figure 1
Figure 1
Effect of mastic gum on cellular production of O2* and H2O2. (A) Production of intracellular O2* was measured by DHE following accumulation of 2-hydroxyethidium using HPLC as described in Materials and Methods [21]. RASMC were stimulated with 20 ng/ml TNF-α for 4-hours. Cells were supplemented with various doses of mastic gum (0-10 μg/ml) for 15-minutes prior to measurements of superoxide. (B) Production of cellular H2O2 was measured by Amplex Red as described in Materials and Methods [21]. RASMC were stimulated with 20 ng/ml TNF-α for 4-hours and then supplemented with various doses of mastic gum (0-10 μg/ml) for 15-minutes prior to measurements of H2O2. *P < 0.01 vs Control, **P < 0.01 vs TNF-α. (C) Superoxide production in bovine aortic endothelial cells (BAEC) stimulated with 200 nM angiotensin II (Ang II) for 4-hours and treated with mastic gum. Control unstimulated BAEC or Ang II-stimulated BAEC were supplemented with 10 μg/ml mastic gum for 15-minutes prior to measurements of superoxide. Data are average from six to eight separate experiments ± Standard Error. *P < 0.01 vs Control, **P < 0.01 vs Ang II.
Figure 2
Figure 2
Spin trapping study of superoxide scavenging by mastic gum. (A) ESR spectrum of EMPO (60 mM) with xanthine (50 μM) and xanthine oxidase (20 mU/ml); (B) ESR spectrum of (A) plus 10 μg/ml mastic gum; (C) ESR spectrum of (A) plus 20 μg/ml mastic gum; (D) ESR spectrum of (A) plus 200 μg/ml mastic gum; (E) ESR spectrum of (A) plus 50 U/ml Cu, Zn-SOD. Computer simulation of ESR spectra (hyperfine coupling constants aN = 13.3 G, aHβ = 10.8 G, aHγ = 1.1 G) [41] and inhibition by SOD (E) confirmed detection of EMPO/*OOH radical adduct. ESR settings were as described in Materials and Methods.
Figure 3
Figure 3
Inhibition of NADPH oxidase in TNF-α stimulated cells treated with mastic gum and attenuation PMA-stimulated superoxide production. (A) Activity of NADPH oxidase was measured as NADPH-dependent O2* production in membrane fractions using ESR as described in Materials and Methods [22]. NADPH oxidase activity was analyzed in membrane fractions of control unstimulated RASMC or RASMC stimulated with 20 ng/ml TNF-α for 4-hours. Mastic gum (10 μg/ml) was applied for 15-minutes prior to isolation of membrane fractions. Direct supplementation of mustic gum to membrane fractions isolated from control or TNF-α stimulated RASMC did not affect NADPH oxidase activity. Data are average from three to six separate experiments ± Standard Error (*P < 0.01 vs Control, **P < 0.01 vs TNF-α). (B) Production of intracellular O2* was measured by DHE following accumulation of 2-hydroxyethidium using HPLC [21] in control or PMA-stimulated RASMC (1 μM PMA, 4-hours) supplemented with various doses of mastic gum (0-10 μg/ml) for 15-minutes prior to measurements of superoxide. Data are average from six separate experiments ± Standard Error (*P < 0.01 vs Control, #P < 0.05 vs TNF-α, **P < 0.01 vs TNF-α).
Figure 4
Figure 4
Inhibition of PKC activity by mastic gum. PKC kinase activity was measured by ELISA-based assay from Enzo Life Sciences in the samples with purified PKC (60 ng) or homogenate of PMA-stimulated RASMC (30 μg). Purified PKC was briefly incubated with 0, 0.1, 1.0 or 10 μg/ml mastic gum prior to PKC activity assay (A). PMA-stimulated RASMC were supplemented with 10 μg/ml mastic gum, 1 μM Go6983 or DMSO as a vehicle for 15-minutes prior to measurements of PKC activity. Data are average from four separate experiments ± Standard Error (*P < 0.01 vs Control, **P < 0.05 vs 0.1 μg/ml Mastic gum).
Figure 5
Figure 5
Proposed mechanism of antioxidant activity of mastic gum via inhibition of PKC-dependent activation of NADPH oxidases.

References

    1. Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R. The Jerusalem Balsam: from the Franciscan Monastery in the old city of Jerusalem to Martindale 33. J Ethnopharmacol. 2005;101:16–26. doi: 10.1016/j.jep.2005.03.028.
    1. Wellmann M. Pedanii Dioscuridis Anazarbei de materia medica libri quinque. Berlin: Weidmann; 1907.
    1. Triantafyllou A, Chaviaras N, Sergentanis TN, Protopapa E, Tsaknis J. Chios mastic gum modulates serum biochemical parameters in a human population. J Ethnopharmacol. 2007;111:43–49. doi: 10.1016/j.jep.2006.10.031.
    1. Al-Said MS, Ageel AM, Parmar NS, Tariq M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol. 1986;15:271–278. doi: 10.1016/0378-8741(86)90165-0.
    1. Takahashi K, Fukazawa M, Motohira H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. J Periodontol. 2003;74:501–505. doi: 10.1902/jop.2003.74.4.501.
    1. Mahmoudi M, Ebrahimzadeh MA, Nabavi SF, Hafezi S, Nabavi SM, Eslami S. Antiinflammatory and antioxidant activities of gum mastic. Eur Rev Med Pharmacol Sci. pp. 765–769.
    1. Assimopoulou AN, Papageorgiou VP. GC-MS analysis of penta- and tetra-cyclic triterpenes from resins of Pistacia species. Part I. Pistacia lentiscus var. Chia. Biomed Chromatogr. 2005;19:285–311. doi: 10.1002/bmc.454.
    1. Assimopoulou AN, Papageorgiou VP. GC-MS analysis of penta- and tetra-cyclic triterpenes from resins of Pistacia species. Part II. Pistacia terebinthus var. Chia. Biomed Chromatogr. 2005;19:586–605. doi: 10.1002/bmc.484.
    1. Sanz MJ, Terencio MC, Paya M. Isolation and hypotensive activity of a polymeric procyanidin fraction from Pistacia lentiscus L. Pharmazie. 1992;47:466–467.
    1. Koutsoudaki C, Krsek M, Rodger A. Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus Var. chia. J Agric Food Chem. 2005;53:7681–7685. doi: 10.1021/jf050639s.
    1. Magiatis P, Melliou E, Skaltsounis AL, Chinou IB, Mitaku S. Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia. Planta Med. 1999;65:749–752. doi: 10.1055/s-2006-960856.
    1. Balan KV, Prince J, Han Z, Dimas K, Cladaras M, Wyche JH, Sitaras NM, Pantazis P. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia. Phytomedicine. 2007;14:263–272. doi: 10.1016/j.phymed.2006.03.009.
    1. Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papapeorgiou VP. Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation. Phytother Res. 2003;17:501–507. doi: 10.1002/ptr.1185.
    1. Dedoussis GV, Kaliora AC, Psarras S, Chiou A, Mylona A, Papadopoulos NG, Andrikopoulos NK. Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis. 2004;174:293–303. doi: 10.1016/j.atherosclerosis.2004.02.011.
    1. Janakat S, Al-Merie H. Evaluation of hepatoprotective effect of Pistacia lentiscus, Phillyrea latifolia and Nicotiana glauca. J Ethnopharmacol. 2002;83:135–138. doi: 10.1016/S0378-8741(02)00241-6.
    1. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens. 2005;14:125–131. doi: 10.1097/00041552-200503000-00007.
    1. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J. 1998;329(Pt 3):653–657.
    1. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. pp. 1603–1616.
    1. Duling DR. Simulation of multiple isotropic spin-trap EPR spectra. J Magn Reson B. 1994;104:105–110. doi: 10.1006/jmrb.1994.1062.
    1. Griendling KK, Taubman MB, Akers M, Mendlowitz M, Alexander RW. Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem. 1991;266:15498–15504.
    1. Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension. 2007;49:717–727. doi: 10.1161/01.HYP.0000258594.87211.6b.
    1. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med. 2008;45:1340–1351. doi: 10.1016/j.freeradbiomed.2008.08.013.
    1. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449–2460. doi: 10.1084/jem.20070657.
    1. Olson JS, Ballou DP, Palmer G, Massey V. The mechanism of action of xanthine oxidase. J Biol Chem. 1974;249:4363–4382.
    1. Zhang H, Joseph J, Vasquez-Vivar J, Karoui H, Nsanzumuhire C, Martasek P, Tordo P, Kalyanaraman B. Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett. 2000;473:58–62. doi: 10.1016/S0014-5793(00)01498-8.
    1. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol. 2005;70:343–354. doi: 10.1016/j.bcp.2005.05.009.
    1. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol. 1997;20 II-11-17.
    1. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494–501.
    1. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108:1253–1258. doi: 10.1161/01.CIR.0000079165.84309.4D.
    1. Dikalov SI, Li W, Mehranpour P, Wang SS, Zafari AM. Production of extracellular superoxide by human lymphoblast cell lines: Comparison of electron spin resonance techniques and cytochrome C reduction assay. Biochem Pharmacol. 2007;73:972–980. doi: 10.1016/j.bcp.2006.12.012.
    1. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43:4–15. doi: 10.1016/j.freeradbiomed.2007.03.024.
    1. Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol. 2009;30:653–661.
    1. Gould CM, Newton AC. The life and death of protein kinase C. Curr Drug Targets. 2008;9:614–625. doi: 10.2174/138945008785132411.
    1. Lee MR, Duan W, Tan SL. Protein kinase C isozymes as potential therapeutic targets in immune disorders. Expert Opin Ther Targets. 2008;12:535–552. doi: 10.1517/14728222.12.5.535.
    1. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471–478. doi: 10.1016/S0165-6147(03)00233-5.
    1. Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol. 2005;78:862–870. doi: 10.1189/jlb.1004583.
    1. Sterer N, Nuas S, Mizrahi B, Goldenberg C, Weiss EI, Domb A, Davidi MP. Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation. J Dent. 2008;36:535–539. doi: 10.1016/j.jdent.2008.04.001.
    1. He ML, Li A, Xu CS, Wang SL, Zhang MJ, Gu H, Yang YQ, Tao HH. Mechanisms of antiprostate cancer by gum mastic: NF-kappaB signal as target. Acta Pharmacol Sin. 2007;28:446–452. doi: 10.1111/j.1745-7254.2007.00536.x.
    1. Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D, Skaltsounis AL. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother. 2007;51:551–559. doi: 10.1128/AAC.00642-06.
    1. He ML, Yuan HQ, Jiang AL, Gong AY, Chen WW, Zhang PJ, Young CY, Zhang JY. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells. Cancer. 2006;106:2547–2555. doi: 10.1002/cncr.21935.
    1. Stolze K, Udilova N, Rosenau T, Hofinger A, Nohl H. Spin adduct formation from lipophilic EMPO-derived spin traps with various oxygen- and carbon-centered radicals. Biochem Pharmacol. 2005;69:297–305. doi: 10.1016/j.bcp.2004.09.021.

Source: PubMed

3
Subscribe